#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loeys-Dietz syndrome Cystic fibrosis respiratory infection suppression Central nervous system neoplasm Waldenstrom's macroglobulinaemia refractory Brain injury Malignant glioma Fatty acid oxidation disorder Anaplastic large cell lymphoma T- and null-cell types Fungal infection T-cell lymphoma Malignant oligodendroglioma Advanced systemic mastocytosis Oesophageal squamous cell carcinoma stage II Arterial disorder Chronic lymphocytic leukaemia recurrent More trials…

    Learn about Rare Diseases

    Fabry’s disease – Basic Information Breast angiosarcoma Mitochondrial myopathy – Life with Disease Richter’s syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts Haemophilia B without inhibitors – Diagnostics Rhabdomyosarcoma recurrent Pulmonary fibrosis – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Alagille syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludrocortisone Acetate Flecainide Chlorhexidine Gluconate MZE829 F770/05 Piritramide Rosuvastatin TRV045 GSKVX000000040033 TETRODOTOXIN Valganciclovir Tramadol Brimonidine Tartrate Eprosartan Mesilate L-Lysine Hydrochloride Olaparib Bms-986288 Lna043 Procarbazine TRIACYLGLYCEROL LIPASE More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage II Aplastic anaemia Neuroblastoma recurrent Synovial sarcoma metastatic Pancreatic carcinoma recurrent Actinic keratosis Gout Oxygen therapy Trigeminal neuralgia Ankylosing spondylitis Tachypnoea Breast cancer Hepatic angiosarcoma Meniscus operation Follicular lymphoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic mastocytosis

  • Study on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Fexofenadine Hydrochloride
    • Dupilumab
    • Sodium Chloride
    Poland

  • Study of Avapritinib for Adults with Systemic Mastocytosis Who Previously Participated in an Avapritinib Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Avapritinib
    Belgium France Germany Italy The Netherlands Norway +2

  • Study of BLU-263 and Azacitidine for Patients with Advanced Systemic Mastocytosis and Other KIT Altered Blood Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Blu-263 Phosphate
    • Azacitidine
    Belgium France Germany The Netherlands Norway Spain

  • Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
    Austria Belgium Czechia France Germany Greece +6

  • Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

    Not recruiting

    2 1
    Investigated Drugs:
    • Avapritinib
    Belgium Denmark France Germany Italy The Netherlands +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!